亿胜生物科技有限公司

年報2009ANNUALREPORT2009ESSEXBIO-TECHNOLOGYLIMITED億勝生物科技有限公司(IncorporatedintheCaymanIslandswithlimitedliability)(StockCode:8151)ESSEXBIO-TECHNOLOGYLIMITED億勝生物科技有限公司(於開曼群島註冊成立之有限公司)(股份代號:8151)AnnuAlRepoRt2009年報ESSEXBIO-TECHNOLOGYLIMITED億勝生物科技有限公司(1)(2)(3)24561213192324252627293071二零零九年年報主席報告25.6%財務摘要47.1%11,600,00025.6%15.1%116,700,00021,600,000 33.3 24.6116.7 92.93.3 0.111.6 21.867,700,00049,900,000億勝生物科技有限公司主席報告業務回顧8,000,0009,061,60025.6%20展望13,398.99致意0.01二零零九年年報公司資料總辦事處暨主要營業地點168-2002818核數師主要股份過戶登記處ButterfieldFulcrumGroup(Cayman)LimitedButterfieldHouse68FortStreetP.O.Box609GrandCaymanKY1-1107CaymanIslands香港股份過戶登記處183171712-1716主要往來銀行股份代號8151董事會MauffreyBenoitJeanMarie公司秘書MBA,ACA,CPA(practising)規章主任審核委員會MauffreyBenoitJeanMarie獲授權代表網址億勝生物科技有限公司財務摘要 116,688,187 92,868,33611,550,889 21,826,710130,493,327 18,974,106(22,459,022 )(72,199,970 )108,034,305 113,774,136– (10,876,60 )108,034,305 102,897,486二零零九年年報管理層討論及分析業務回顧及前景25.6%8,000,0009,061,600市場開發分銷網絡3201,00014054030,000新產品GMP億勝生物科技有限公司管理層討論及分析市場開發（續）榮譽1.52.60業務聯繫人士InSiteInSiteInSiteAzaSite®AzaSite®ABCFarmaceuticiS.P.A.ABCFarmaceuticiS.P.A.ABCABCLatanoprostOphthalmicSolution二零零九年年報管理層討論及分析市場開發（續）合作協議ISO-90011)BetaxololHydrochlorideEyeDrop2)TosufloxacinTosylateEyeDrop研究及開發（「研發」）億勝生物科技有限公司管理層討論及分析研究及開發（「研發」）（續）rh-bFGFrh-GDNFrh-GDNF財務回顧116,700,00025.6%84,000,000105,600,00090%18,700,00015.1%21,600,00016,500,0001.6%16,800,00021,800,00011,600,00069,600,00055,100,00015,300,00011,600,000二零零九年年報10管理層討論及分析財務回顧（續）67,700,00049,900,00034,600,000重大收購及出售附屬公司╱重大投資的未來計劃EssexBio-InvestmentLimitedEssexBio-InvestmentLimited8,000,0009,061,60013,398.99資本結構重大投資資本負債比率16.4%億勝生物科技有限公司11管理層討論及分析流動資金及財務資源67,700,00049,900,000外匯風險集團資產抵押或然負債分部資料4345僱員17913,900,00019,500,0007,400,0006364316%5,000,000嚴名熾55KPMGDHLBusinessmanoftheYearChevalierDEL’ORDRENATIONALDUMERITEEssexBio-InvestmentLimited方海洲44EssexBio-InvestmentLimited鐘聲4511EssexBio-InvestmentLimited馮志英55MauffreyBenoitJeanMarie57邱梅美47TheUniversityofSouthwesternLouisianaTheUniversityofNewEngland18二零零九年年報董事履歷12億勝生物科技有限公司董事會報告13主要業務32業績及股息24700.01暫停辦理股東登記手續183171712-1716財務概要7172物業、廠房及設備17股本及購股權2731二零零九年年報董事會報告14足夠公眾持股量優先購買權購買、贖回或出售本公司之上市證券儲備2826可供分派儲備7,929,5285,567,500主要客戶與供應商21.8%5.5%54.3%13.0%5%億勝生物科技有限公司董事會報告15董事執行董事：獨立非執行董事：MauffreyBenoitJeanMarie董事的服務合約1910161161A5.09董事於重大合約的權益38二零零九年年報董事會報告16董事及行政總裁於股份、相關股份及債券的權益及淡倉XV3525.46於本公司普通股的好倉：0.102,250,000–288,458,000–297,374,66753.4116,666,66722,000,000–––2,000,0000.361,500,000–––1,500,0000.271288,458,00050%26,666,667DynatechVenturesPteLtdDynatechDynatechDynatech於本公司相聯法團普通股中的好倉：5,00050.003525.46億勝生物科技有限公司董事會報告17董事購買股份或債券的權利主要股東及其他人士於股份及相關股份的權益及淡倉336288,458,00051.81295,449,66753.071297,374,66753.412KeeSueHwa32,476,0005.831.(a)325,000(b)288,458,000(c)6,666,667Dynatech2.(a)297,374,667336二零零九年年報董事會報告18關連及有關連人士交易38競爭及利益衝突核數師企業管治1922億勝生物科技有限公司19企業管治報告緒言董事進行證券交易5.485.67董事會及董事會會議MauffreyBenoitJeanMarie二零零九年年報20企業管治報告董事會及董事會會議（續）4/44/44/44/4MauffreyBenoitJeanMarie4/44/4董事薪酬MauffreyBenoitJeanMarie1/11/11/1MauffreyBenoitJeanMarie1/1億勝生物科技有限公司21企業管治報告董事提名MauffreyBenoitJeanMarie1/11/1MauffreyBenoitJeanMarie1/11/1審核委員會5.285.33MauffreyBenoitJeanMarie4/4MauffreyBenoitJeanMarie4/44/4二零零九年年報22企業管治報告審核委員會（續）核數師酬金430,000董事及核數師對賬目之責任23內部監控投資者關係億勝生物科技有限公司23獨立核數師報告2470P03752二零零九年年報24綜合全面收益表7116,688,187 92,868,336(11,038,491 ) (8,854,289) 105,649,696 84,014,0478833,569 1,393,583(69,618,126 ) (55,061,490)(15,301,513 ) (11,603,748) 9(a)21,563,626 18,742,39213(4,810,871 ) (2,257,169) 16,752,755 16,485,2239(b)(8,594,063 ) 10,473,459 8,158,692 26,958,682 109,805 3,922,64833 (956,375 )– (846,570 )3,922,648 7,312,122 30,881,330 11,550,889 21,826,710(3,392,197 ) 5,131,972 8,158,692 26,958,682 10,704,319 25,395,559 (3,392,197 )5,485,771 7,312,122 30,881,330 162.07 3.92 163.00 2.96 億勝生物科技有限公司25綜合財務狀況報表175,939,80124,404,633187,260,3887,767,640192,278,4892,383,299234,500,220–202,891,6982,105,082–2,271,32022,870,59638,931,974212,215,06755,446,3982235,150,47836,875,6852,516,1242,503,44024–2,271,3202467,741,06249,945,289107,622,731147,042,132130,493,327185,974,1062519,845,89936,287,957–34,637,6301,533,1231,274,38321,379,02272,199,97086,243,70974,842,162109,114,305113,774,136261,080,000–22,459,02272,199,970108,034,305113,774,1362755,675,00055,675,00052,359,30547,222,486108,034,305102,897,486–10,876,650108,034,305113,774,136二零零九年年報26綜合股本變動表28(i)28(ii)28(iii)55,675,000969,871362,4423,770,6035,281,65311,442,35877,501,9275,390,87982,892,806––––3,568,84921,826,71025,395,5595,485,77130,881,330–––2,118,803–(2,118,803)–––55,675,000969,871362,4425,889,4068,850,50231,150,265102,897,48610,876,650113,774,136––––(846,570)11,550,88910,704,319(3,392,197)7,312,122–––––(5,567,500)(5,567,500)–(5,567,500)–––––––(7,484,453)(7,484,453)–––2,474,078–(2,474,078)–––55,675,000969,871362,4428,363,4848,003,93234,659,576108,034,305–108,034,305155,567,50097,329,986102,897,486155,567,500102,466,805108,034,305億勝生物